The self-report Panic Disorder Severity Scale (PDSS, also known as the PDSS-SR; Houck et al., 2002) is a 7-item measure that assesses the overall severity of panic disorder in individuals aged 18+ with an established or suspected diagnosis. The PDSS captures panic attack frequency, panic-related distress, anticipatory anxiety, avoidance behaviour, and functional impairment over the past week. For respondents aged 8-17, the Revised Child Anxiety and Depression Scale (RCADS-Child) Panic Disorder subscale is available on NovoPsych as an age-appropriate alternative.
Each item is rated on a 5-point scale, where 0 represents the complete absence of panic disorder symptoms (e.g., ‘not at all distressing’, ‘no panic’) and 4 represents the most severe level (e.g., ‘extremely distressing’, ‘nearly constant’) over the past week. Response anchors vary across items but follow the same severity progression. The PDSS total score is the sum of all seven items, yielding a possible range of 0 to 28. Higher scores indicate greater panic disorder symptom severity. In addition to the total score, a composite score (average of all items) is computed and ranges from 0 to 4.
To support clinical interpretation of the average score (because PDSS does not have published empirical cut-off scores for severity classification), the composite score is categorised below using the response scale anchors built into the measure itself. Each PDSS item is rated on a 0–4 scale, where 0 = absent, 1 = mild, 2 = moderate, 3 = severe, and 4 = extreme, and the severity descriptors below apply these same anchors to the average score across all seven items.
Note: These are response-scale-derived categories, not empirically validated diagnostic thresholds. Because the average score summarises across all seven items, high distress in specific domains may be masked by lower scores elsewhere. Clinicians should review individual item scores. Any item rated 3 (severe) or 4 (extreme) may indicate significant impairment in that domain, even if the overall average is lower.
Results are presented in a summary table reporting the total score, average score, and severity descriptor.
A horizontal bar chart is displayed on the first administration only, and shows the respondent’s average score as a horizontal bar against colour-coded severity descriptor bands spanning the 0 to 4 scale.
The PDSS item responses chart displays each of the seven PDSS domains as a horizontal bar on the 0-4 response scale. This visual profile allows clinicians to quickly identify which specific domains are driving the respondent’s overall score and where the greatest difficulties lie. As each item uses domain-specific response anchors, the severity band descriptors from the average score chart are not applied here.
A line plot is displayed when two or more administrations of the PDSS are completed. It plots the respondent’s average score over time, with each data point labelled with its value and the administration date on the horizontal axis.
The PDSS items are displayed as individual line graphs across administrations, with domain-specific severity descriptors reflecting the unique response anchors for each item. These charts allow clinicians to monitor changes in specific domains over time and identify patterns that may not be apparent from the average score alone.
When PDSS scores are available from multiple timepoints, changes in scores from the baseline administration can provide valuable information about the effectiveness of interventions or symptom trajectory. Changes of at least 0.5 standard deviations on measures are generally considered the minimally important difference (MID; Norman et al., 2003; Turner et al., 2010).
Based on a standard deviation of 6.6 from a self-report clinical sample using the full 7-item PDSS (Houck et al., 2002, N = 108, SD = 6.6), the minimally important difference for the PDSS total score is 3 points.
Changes in PDSS total scores are categorised as:
The PDSS was originally developed by Shear and colleagues (1997) as a brief clinician-administered measure of panic disorder severity, modelled after the Yale-Brown Obsessive Compulsive Scale (Y-BOCS). It was later adapted into a self-report format (the PDSS-SR) to enable practical, repeated symptom monitoring without the need for a trained interviewer (Houck et al., 2002). Houck and colleagues (2002) found a strong correspondence between the self-report and clinician-administered versions (ICC = .81), though self-report scores were on average 2.5 points lower than clinician-rated scores. The self-report version demonstrated comparable internal consistency, test-retest reliability, and sensitivity to change.
The PDSS self-report version is scored as a unidimensional measure, consistent with the single-factor structure established for the clinician-administered version (Shear et al., 2001), and uses the same seven items and response format (Houck et al., 2002).
The PDSS self-report version demonstrates good to excellent internal consistency. Houck and colleagues (2002) reported excellent internal consistency in a psychiatric outpatient sample (Cronbach’s alpha = .92; N = 108), while Wuyek and colleagues (2011) reported good internal consistency in a clinical sample of patients with panic disorder (Cronbach’s alpha = .8; N = 52). However, the Wuyek sample completed a five-item version of the self-report PDSS that excluded the work and social impairment items and therefore, reliability for the full seven-item self-report version is best represented by the Houck et al. (2002) estimate.
Test-retest reliability of the PDSS is satisfactory, with Houck et al. (2002) reporting an ICC of .83 over two consecutive days, supporting the stability of scores in the absence of clinical change.
The PDSS self-report version total score demonstrates good convergent validity. Roberge and colleagues (2022) reported moderate to strong associations with related measures in a sample of 256 adults with panic disorder, including the Beck Anxiety Inventory (r = .63), the Anxiety Disorders Interview Schedule panic disorder severity rating (r = .56), and the Mobility Inventory for Agoraphobia (r = .47 to .50). Weaker associations were observed with measures of constructs less central to panic disorder, such as the Social Phobia Inventory (r = .17) and the Penn State Worry Questionnaire (r = .11), supporting discriminant validity. Validity evidence is strongest at the total score level, and clinicians are encouraged to interpret the composite score accordingly.
Houck and colleagues (2002) reported a mean decrease of 7.3 points (SD = 5.1) on the PDSS self-report version total score (0 to 28 scale) following cognitive-behavioural treatment, corresponding to improvement from a pre-treatment average of 13.3 to a post-treatment average of 6.1. These findings support the use of the PDSS for being sensitive to clinically meaningful change as part of monitoring treatment response over time.
The PDSS is designed for individuals aged 18 and over with an established or suspected diagnosis of panic disorder. For respondents aged 8-17, the Revised Child Anxiety and Depression Scale (RCADS-Child) Panic Disorder subscale is available on NovoPsych as an age-appropriate alternative.
Yes. The PDSS is sensitive to treatment-related change. A change of 3 or more points on the total score is considered clinically meaningful. On repeat administration, the NovoPsych report includes a change score comparison against the initial administration and item-level tracking charts for each domain.
No. The PDSS measures panic disorder symptom severity and is not intended as a diagnostic instrument. It is designed for use with individuals who already have an established or suspected diagnosis of panic disorder.
Panic disorder is characterised by recurrent, unexpected panic attacks involving intense physical symptoms such as rapid heartbeat, shortness of breath, chest pain, dizziness, and sweating. Between attacks, individuals typically experience persistent worry about future attacks (anticipatory anxiety) and may develop avoidance of situations or physical sensations associated with panic. It may occur with or without agoraphobia, and comorbidity with other conditions such as depression and generalised anxiety is common.
Panic disorder can impair functioning across multiple life domains. Work productivity and reliability may decline due to avoidance of triggering environments or difficulty concentrating during periods of heightened anxiety. Social activities may narrow as individuals avoid situations where panic attacks have occurred or where escape would be difficult. Physical sensations associated with exercise, caffeine, or excitement may also be avoided, further restricting daily life.
Houck, P. R., Spiegel, D. A., Shear, M. K., & Rucci, P. (2002). Reliability of the self-report version of the Panic Disorder Severity Scale. Depression and Anxiety, 15, 183–185. https://doi.org/10.1002/da.10049
Roberge, P., Marx, P., Couture, J., Carrier, N., Benoît, A., Provencher, M. D., Antony, M. M., & Norton, P. J. (2022). French adaptation and validation of the Panic Disorder Severity Scale—self-report. BMC Psychiatry, 22, Article 434. https://doi.org/10.1186/s12888-022-03989-x
Shear, M. K., Brown, T. A., Barlow, D. H., Money, R., Sholomskas, D. E., Woods, S. W., Gorman, J. M., & Papp, L. A. (1997). Multicenter collaborative Panic Disorder Severity Scale. American Journal of Psychiatry, 154, 1571–1575.
Shear, M. K., Rucci, P., Williams, J., Frank, E., Grochocinski, V., Vander Bilt, J., Houck, P., & Wang, T. (2001). Reliability and validity of the Panic Disorder Severity Scale: Replication and extension. Journal of Psychiatric Research, 35, 293–296.
Houck, P. R., Spiegel, D. A., Shear, M. K., & Rucci, P. (2002). Reliability of the self-report version of the Panic Disorder Severity Scale. Depression and Anxiety, 15, 183–185. https://doi.org/10.1002/da.10049
Kessler, R. C., Chiu, W. T., Jin, R., Ruscio, A. M., Shear, K., & Walters, E. E. (2006). The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Archives of General Psychiatry, 63(4), 415–424. https://doi.org/10.1001/archpsyc.63.4.415
Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2003). Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation. Medical Care, 41(5), 582–592. https://doi.org/10.1097/01.MLR.0000062554.74615.4C
Turner, D., Schünemann, H. J., Griffith, L. E., Beaton, D. E., Griffiths, A. M., Critch, J. N., & Guyatt, G. H. (2010). The minimal detectable change cannot reliably replace the minimal important difference. Journal of Clinical Epidemiology, 63(1), 28–36. https://doi.org/10.1016/j.jclinepi.2009.01.024
Wuyek, L. A., Antony, M. M., & McCabe, R. E. (2011). Psychometric properties of the Panic Disorder Severity Scale: Clinician-administered and self-report versions. Clinical Psychology and Psychotherapy, 18, 234–243. https://doi.org/10.1002/cpp.703